Metric Snapshot
- Latest value
- 5.4%
- Coverage range
- 31 Dec 2010 - 30 Sep 2011
- Fact rows
- 5
Shareable Research Card
VTR - Ventas, Inc. Return On Equity
This metric view shows VTR - Ventas, Inc. return on equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q3 2011
- Latest reported value
- 5.4%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
Ventas, Inc.: Return On Equity
Latest period: Q3 2011. Period end: 30 Sep 2011. Units: %. Frequency: quarterly and annual.
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
What This Metric Tells You
- Shows the reported level of return on equity over 31 Dec 2010 - 30 Sep 2011.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 5 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Wellgistics Health, Inc. (["wgrx"]) | 141760% | Year - 31 Dec 2025 | Open Wellgistics Health, Inc. Return On Equity |
| 2 | XCF Global, Inc. (["safx"]) | 77635% | Year - 31 Dec 2025 | Open XCF Global, Inc. Return On Equity |
| 3 | Cardiff Lexington Corp (["cdix"]) | 49573% | Year - 31 Dec 2025 | Open Cardiff Lexington Corp Return On Equity |
| 4 | Bionik Laboratories Corp. (["bnkl"]) | 46191% | Quarter - 31 Mar 2023 | Open Bionik Laboratories Corp. Return On Equity |
| 5 | Savara Inc (["svra"]) | 43610% | Quarter - 31 Dec 2025 | Open Savara Inc Return On Equity |
| 6 | Athenex, Inc. ([]) | 25553% | Year - 31 Dec 2022 | Open Athenex, Inc. Return On Equity |
Metric Details
- Metric
- Return On Equity (ROE)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2010 - 30 Sep 2011
- Facts on this page
- 5
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Equity, Quarterly (%)
Return On Equity, Annual (%)
Ventas, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q3 2011 | 5.4% | 01 Jul 2011 | 30 Sep 2011 | ||
| Q2 2011 | 7.2% | 01 Apr 2011 | 30 Jun 2011 | ||
| Q1 2011 | 9.8% | 01 Jan 2011 | 31 Mar 2011 | ||
| Q4 2010 | 10% | 01 Oct 2010 | 31 Dec 2010 |
Ventas, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2010 | 10% | 01 Jan 2010 | 31 Dec 2010 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.